Remove Clinical Trials Remove Epilepsy Remove Extraction Remove Research and Development
article thumbnail

Marijuana Associated With Improvement in Symptoms Related to Autism, Finds Case Study

The Joint Blog

According to a new study published in the Journal of Medical Case Reports , the daily use of high-CBD (cannabidiol) marijuana extracts is associated with improvements in the behavioral symptoms related to autism spectrum disorder (ASD). The individual was given very low-doses of marijuana extracts, no larger than 0.2 ml twice daily.

article thumbnail

United States Minor Cannabinoids (CBG, CBC, CBN, THCV, CBGA) Markets Report 2021-2028 – ResearchAndMarkets.com

Cannabis Law Report

This high share is attributable to the rising adoption of THCV for various applications such as epilepsy, arthritis, metabolic disorders, neurological disorders, and pain management. Rising clinical trials is thus anticipated to boost the adoption and penetration of rare cannabis derivatives in the forthcoming years.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Using Cannabis for ALS: Benefits, Research and Best Strains

Greencamp

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94
article thumbnail

What is CBD? Everything you need to know

The Cannigma

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122
article thumbnail

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

Adverse mental events were reported as well, however, more research should be performed to assess well this outcome. This trend is also observed in the pediatric population, where MCs are authorized in children for refractory epilepsy, especially in Dravet syndrome and Lennox-Gastaut syndrome 2. Data extraction. Introduction.

Safety 52
article thumbnail

CBD: Everything You Need to Know

CannaMD

Researchers believe cannabis contains over 100 unique chemical compounds! government classified all cannabis varieties, including hemp, as Schedule I under the Controlled Substances Act (despite decades of agricultural research detailing its differences from marijuana). What makes CBD special? In 1970, the U.S. Glad you asked!

CBD 99
article thumbnail

Global Cannabis Market Size & Forecast Report 2021: A $176 Billion by 2030 – Growing Legalization of Medical Cannabis in Various Countries Driving Growth – ResearchAndMarkets.com

Cannabis Law Report

The smoke is released by heating cannabis leaves, extracts with psychoactive chemicals. Oils extracted from cannabis have various benefits and advantages in medical, food & beverage, and personal care industries. Product Development Via Research and Novel Product Delivery Solutions. Opportunities. Challenges.

Indica 52